GENMAB A/S: Financial statements 2022
CVR: 21023884
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
GENMAB A/S (CVR 21023884) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 14,595,000,000 and a net result of DKK 5,522,000,000 compared with DKK 3,008,000,000 the year before. That is an increase of 72.1% compared with the year before. The profit margin was 37.8%. Equity in the 2022 report amounted to DKK 27,441,000,000. The solvency ratio was 90.6%. The company had 313 employees in the financial year.
- Revenue
- DKK 14,595,000,000
- Profit/Loss
- DKK 5,522,000,000
- Equity
- DKK 27,441,000,000
- Total Assets
- DKK 30,278,000,000
- Employees
- 313
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 14.6 mia. | - | 5.5 mia. | 27.4 mia. | 313 |
| 2021 | 8.5 mia. | - | 3 mia. | 22.2 mia. | 235 |
| 2020 | 10.1 mia. | - | 4.8 mia. | 19.1 mia. | - |
| 2019 | 5.4 mia. | - | 2.2 mia. | 14 mia. | - |
| 2018 | 3 mia. | - | 1.5 mia. | 8 mia. | - |
Official annual report
Keep an eye on GENMAB A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GENMAB A/S has published its interim report for the period January 1, 2022 – September 30, 2022.
GENMAB A/S has published its interim report for the period January 1, 2022 – June 30, 2022.
GENMAB A/S has published its interim report for the period January 1, 2022 – March 31, 2022.
GENMAB A/S has published its annual report for 2021. Revenue came to DKK 8,482,000,000, and the net result was DKK 3,008,000,000.
As of March 29, 2022, Julie Blædel has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Martin Schultz has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Suzana Sturlini Couto has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Richard Gordon Hibbert has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Elizabeth Grimes O’Farrell has joined the board of directors of GENMAB A/S.
As of March 29, 2022, Takahiro Hamatani has joined the board of directors of GENMAB A/S.
About GENMAB A/S
GENMAB A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GFKJUS 519 ApS. The management consists of Jan van de Winkel and Anthony Michael Pagano. The board consists of Deirdre Patrice Connelly (chair), Pernille Lyngvold Erenbjerg, Anders Gersel Pedersen and Elizabeth Grimes O’Farrell. The company is owned by BLACKROCK, INC. and Darwin Global Management Limited. The company has 676 employees (2026). In 2025, the company reported revenue of USD 3,720,000,000 and a net result of USD 963,000,000 compared with DKK 7,844,000,000 the year before. Equity in the 2025 report amounted to USD 5,847,000,000.